Section Arrow
Quote
OKUR.NASDAQ
- OnKure Therapeutics Inc
Quotes are at least 15-min delayed:2026/04/23 00:12 EDT
Regular Hours
Last
 5.01
+0.13 (+2.66%)
Day High 
5.09 
Prev. Close
4.88 
1-M High
5.08 
Volume 
136.27K 
Bid
4.95
Ask
5.09
Day Low
4.91 
Open
4.91 
1-M Low
3.58 
Market Cap 
66.73M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.61 
20-SMA 4.38 
50-SMA 3.61 
52-W High 5.08 
52-W Low 1.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.40/-2.05
Enterprise Value
66.73M
Balance Sheet
Book Value Per Share
4.11
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.2224+0.0256+13.01%-- 
TOVXTheriva Biologics Inc0.3731+0.0344+10.16%0.09PE
IOVAIovance Biotherapeutics3.53-0.17-4.59%-- 
REPLReplimune Group2.27+0.41+22.04%-- 
GERNGeron Corp1.55+0.05+3.33%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3K. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.